Stock 301096 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Equities

301096

CNE1000056N5

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-11 EDT 		5-day change 1st Jan Change
62.39 CNY +1.13% Intraday chart for Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. +0.48% -4.16%
04-22 Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Announces Cash Dividend for the Year 2023, Payable on 3 June 2024
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback announced on August 24, 2023, has closed with 777,300 shares, representing 0.72% for CNY 49.99 million,
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. authorizes a Buyback Plan.
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Cash Dividend for 2022, Payable on 04 May 2023
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022
CI
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301096 Stock
  4. News Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
  5. Highlights